Kayani I - Search Results

1

The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer.

Moule RN, Kayani I, Moinuddin SA, Meer K, Lemon C, Goodchild K, Saunders MI. Moule RN, et al. Among authors: kayani i. Radiother Oncol. 2010 Nov;97(2):189-93. doi: 10.1016/j.radonc.2010.04.025. Epub 2010 Jun 1. Radiother Oncol. 2010. PMID: 20570004 Clinical Trial.

2

Impact of combined (18)F-FDG PET/CT in head and neck tumours.

Syed R, Bomanji JB, Nagabhushan N, Hughes S, Kayani I, Groves A, Gacinovic S, Hydes N, Visvikis D, Copland C, Ell PJ. Syed R, et al. Among authors: kayani i. Br J Cancer. 2005 Mar 28;92(6):1046-50. doi: 10.1038/sj.bjc.6602464. Br J Cancer. 2005. PMID: 15770212 Free PMC article.

3

18F-fluorodeoxyglucose PET/CT in cancer imaging.

Kayani I, Groves AM. Kayani I, et al. Clin Med (Lond). 2006 May-Jun;6(3):240-4. doi: 10.7861/clinmedicine.6-3-240. Clin Med (Lond). 2006. PMID: 16826854 Free PMC article. Review. No abstract available.

4

The impact of 18F-FDG PET/CT in patients with liver metastases.

Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji JB, Ell PJ. Chua SC, et al. Among authors: kayani i. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1906-14. doi: 10.1007/s00259-007-0518-y. Epub 2007 Aug 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17713766

5

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ. Kayani I, et al. Cancer. 2008 Jun;112(11):2447-55. doi: 10.1002/cncr.23469. Cancer. 2008. PMID: 18383518 Free article.

6

CT coronary angiography: quantitative assessment of myocardial perfusion using test bolus data-initial experience.

Groves AM, Goh V, Rajasekharan S, Kayani I, Endozo R, Dickson JC, Menezes LJ, Shastry M, Habib SB, Ell PJ, Hutton BF. Groves AM, et al. Among authors: kayani i. Eur Radiol. 2008 Oct;18(10):2155-63. doi: 10.1007/s00330-008-0987-9. Epub 2008 May 9. Eur Radiol. 2008. PMID: 18465134

7

Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.

Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, Kayani I, Menezes LJ, Dickson JC, Ell PJ. Groves AM, et al. Among authors: kayani i. J Nucl Med. 2009 Apr;50(4):538-45. doi: 10.2967/jnumed.108.057901. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289428 Free article.

8

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB. Kayani I, et al. J Nucl Med. 2009 Dec;50(12):1927-32. doi: 10.2967/jnumed.109.066639. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910422 Free article.

9

What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque.

Menezes LJ, Kayani I, Ben-Haim S, Hutton B, Ell PJ, Groves AM. Menezes LJ, et al. Among authors: kayani i. Atherosclerosis. 2010 Jul;211(1):136-40. doi: 10.1016/j.atherosclerosis.2010.01.012. Epub 2010 Jan 22. Atherosclerosis. 2010. PMID: 20202634

10

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

Moule RN, Kayani I, Prior T, Lemon C, Goodchild K, Sanghera B, Wong WL, Saunders MI. Moule RN, et al. Among authors: kayani i. Clin Oncol (R Coll Radiol). 2011 Jun;23(5):364-71. doi: 10.1016/j.clon.2010.11.001. Epub 2010 Nov 24. Clin Oncol (R Coll Radiol). 2011. PMID: 21109410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page